Design, synthesis, and biological evaluation of new thiazolo[5,4-]pyrimidine derivatives as potent antiproliferative agents.

Medchemcomm

Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province , Key Laboratory of Technology of Drug Preparation (Zhengzhou University) , Ministry of Education of China , Key Laboratory of Henan Province for Drug Quality and Evaluation , School of Pharmaceutical Sciences , Zhengzhou University, Zhengzhou 450001 , PR China . Email: ; Email:

Published: August 2017

A series of thiazolo[5,4-]pyrimidine derivatives were synthesized and evaluated for their antiproliferative activities against several human cancer cell lines. Structure-activity relationship studies were carried out, showing that most of the target compounds had good inhibition against the tested cell lines. Among them, compound exhibited potent inhibition against human gastric cancer cells MGC-803 and HGC-27 with IC values of 4.64 and 5.07 μM, respectively and around 12-fold selectivity between MGC-803 and GES-1, indicating a relatively low toxicity to normal cells. The potency and low toxicity of compound make the thiazolo[5,4-]pyrimidine an attractive scaffold for designing new derivatives selectively targeting MGC-803 cells.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071795PMC
http://dx.doi.org/10.1039/c7md00165gDOI Listing

Publication Analysis

Top Keywords

thiazolo[54-]pyrimidine derivatives
8
cell lines
8
low toxicity
8
design synthesis
4
synthesis biological
4
biological evaluation
4
evaluation thiazolo[54-]pyrimidine
4
derivatives potent
4
potent antiproliferative
4
antiproliferative agents
4

Similar Publications

Two series of C-Mannich base derivatives were synthesized and evaluated through the reaction of formaldehyde, two thiazolo-pyrimidine compounds, and various 2°-amines. The chemical structures and inherent properties of the synthesized compounds were authenticated using a variety of spectroscopic techniques. The aseptic bactericidal potential of the compounds was assessed alongside five common bacterial microbes, with Ampicillin employed as the reference drug.

View Article and Find Full Text PDF

Relationships between the structures of molecules and their properties form the basis of modern chemistry and lay the foundation for structure-based drug design. Being the main two determinants of bioavailability, solubility and permeability of drugs are widely investigated experimentally and predicted from physicochemical parameters and structural descriptors. In the present study, we measure the passive diffusion permeability of a series of new fluconazole derivatives with triazole and thiazolo-pyrimidine moieties connected by different linker bridges through the PermeaPad barrier-a relatively new biomimetic lipophilic membrane that has been increasingly used in recent years.

View Article and Find Full Text PDF

Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy.

Eur J Med Chem

July 2017

Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China. Electronic address:

A series of thiazolo[5,4-d]pyrimidine derivatives were synthesized and evaluated for their antiproliferative activities on three cancer cell lines. The structure-activity relationship studies were conducted through the variation in the three regions of the thiazolo-pyrimidine core. Substitution with morpholine led to compound 24, which exerted the most potent antiproliferative activity as well as good selectivity between cancer and normal cells (IC values of 1.

View Article and Find Full Text PDF

A series of substituted pyrazole, triazole and thiazole derivatives (2-13) were synthesized from 1-(naphtho[1,2-d]thiazol-2-yl)hydrazine as starting material and evaluated as androgen receptor antagonists and anti-prostate cancer agents. The newly synthesized compounds showed potent androgen receptor antagonists and anti-prostate cancer activities with low toxicity (lethal dose 50 (LD50)) comparable to Bicalutamide as reference drug. The structures of newly synthesized compounds were confirmed by IR, 1H-NMR, 13C-NMR, and MS spectral data and elemental analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!